| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |